Stock losses escalated in the final hour as an increase in Treasury yields hit defensive names in the utilities and materials sectors. Bond prices fell on diminished hopes of further monetary stimulus from some of the world's largest central banks. Bristol-Myers Squibb (BMY) led the healthcare sector after laying out plans to reorganize, including redirecting spending toward key brands. The drugmaker also topped third-quarter earnings and increased its full-year outlook. CenturyLink (CTL) spiked on reports it is in advanced talks to merge with Level 3 Communications (LVLT) . A deal could be announced in weeks. Anadarko (APC) climbed on reports Sanchez (SN) and Blackstone (BX) could team up to purchase its South Texas assets. A deal could value the assets between $3 billion and $3.5 billion. TheStreet's Keris Lahiff has details from Wall Street.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.